LCTX STOCK ANALYSIS
Price summary
Last Close
1.35 $
Jul 2, 26
Market Cap
352.6 M $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+32.4
Volatility
%62.6
Sharpe Ratio
0.12
Sortino Ratio
0.13
Distance to Peak
%-31.1
Maximum Drawdown
-%39.3
Seasonality
Seasonality Chart
Periodic Returns
1M
+11.6%
3M
-14.0%
6M
-19.2%
YTD
-19.2%
1Y
+32.4%
3Y
-4.3%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current Lineage Cell Therapeutics Inc (LCTX) stock price?
LCTX last closed at 1.35 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the market capitalization of Lineage Cell Therapeutics Inc?
Lineage Cell Therapeutics Inc (LCTX) has a market capitalization of approximately 352.6 M $ as of the latest reported period.
Who are the main competitors of LCTX?
Key peers of Lineage Cell Therapeutics Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.. A detailed metric comparison is available on the Peers tab.
Go deeper on LCTX
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
